India’s Pharma Revolution: From Generic Giant to Innovation Powerhouse
From the dusty manufacturing units churning out affordable medicines to state-of-the-art biosimilar laboratories serving global markets, India’s pharmaceutical journey reads like a masterclass in strategic transformation. As exports surge towards the $30 billion milestone in 2025, the world’s ‘pharmacy’ is no longer content with merely filling prescriptions—it’s rewriting them. This seismic shift from volume-driven generics […]
India’s Pharma Revolution: From Generic Giant to Innovation Powerhouse Read More »










